A Randomized, Open Label, Multiple-Dose, Cross-over Clinical Study to Investigate Pharmacokinetics and Drug-Drug Interaction Between Rosuvastatin and CS-866 in Healthy Male Volunteers.

Trial Profile

A Randomized, Open Label, Multiple-Dose, Cross-over Clinical Study to Investigate Pharmacokinetics and Drug-Drug Interaction Between Rosuvastatin and CS-866 in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Rosuvastatin (Primary)
  • Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias; Hypercholesterolaemia; Hyperlipidaemia; Hypertension; Hypertriglyceridaemia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 17 Apr 2013 Last checked against ClinicalTrials.gov record (NCT01831479).
    • 17 Apr 2013 Last checked against ClinicalTrials.gov record (NCT01831479).
    • 09 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top